In addition, high serum AFP level has been identified as a biomarker for HCC associated with a more aggressive tumor phenotype and inferior outcomes after different treatment modalities in accordance with our statistical analyses (23). The gene discussed is AFP; the disease is hepatocellular carcinoma.